Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Monocytic, Acute × tipifarnib × 90 days × Clear all

Sponsor

Conditions

Neuroblastoma 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Histiocytosis, Langerhans-Cell 1 Histiocytic Sarcoma 1 Hereditary Sensory and Autonomic Neuropathies 1 Hepatoblastoma 1 Head and Neck Neoplasms 1 Glioma 1 Ependymoma 1 Central Nervous System Neoplasms 1

Interventions

Injections 2 Gemtuzumab 2 Decitabine 2 ruxolitinib 1 fludarabine 1 fedratinib 1 Whole-Body Irradiation 1 Thiotepa 1 Tacrolimus 1 Sirolimus 1 Peripheral Blood Stem Cell Transplantation 1 Methotrexate 1 Daunorubicin 1 Cytarabine 1 Cyclosporins 1 Cyclosporine 1 Cyclophosphamide 1 Busulfan 1 Biopsy 1 Azacitidine 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡